HomeProductsBioactive CompoundsGPCR & G Protein TargetsAdenosine ReceptorRegadenoson
Chemical structure of CAS 313348-27-5

Regadenoson

In Stock•Starting at $78 for 100 mg•Purity ≥ 98%
CAS No.313348-27-5
MDL No.N/A
MFC15H18N8O5
MW390.35
InChI KeyLZPZPHGJDAGEJZ-AKAIJSEGSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg98%$78In Stock
250 mg98%$132In Stock
1 g98%$352In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Regadenoson is a purine nucleoside.

CAS No.313348-27-5
Product NameRegadenoson
Acute ToxicAcute Toxic
IrritantIrritant
Health HazardHealth Hazard
Signal Word:Danger
HCode:H300-H302-H310-H312-H315-H319-H330-H332-H370
PCode:P260-P261-P262-P264-P264+P265-P270-P271-P280-P284-P301+P316-P301+P317-P302+P352-P304+P340-P305+P351+P338-P308+P316-P316-P317-P320-P321-P330-P332+P317-P337+P317-P361+P364-P362+P364-P403+P233-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

Selective adenosine agonists and myocardial perfusion imaging.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology • Vol. 19, Issue 1 • 2012
PMID: 22130964DOI: 10.1007/s12350-011-9474-9

New stress test agents reduce adverse effects.

JAMA • Vol. 299, Issue 18 • 2008
PMID: 18477777DOI: 10.1001/jama.299.18.2140

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology • Vol. 14, Issue 4 • 2007
PMID: 17679059DOI: 10.1016/j.nuclcard.2007.02.016

Adenosine receptors as therapeutic targets.

Nature reviews. Drug discovery • Vol. 5, Issue 3 • 2006
PMID: 16518376PMC: PMC3463109DOI: 10.1038/nrd1983

Documentation

Similar Products